SAEFVIC general support

Reports are only accepted online. Reports via telephone, fax or email will not be accepted. To report an AEFI for yourself or a patient please visit SAEFVIC for reporting guidelines and instructions.

For information on which symptoms following immunisation should be reported refer to SAEFVIC.

Not all reports will receive follow up.  SAEFVIC is a reporting service and not an emergency contact. Hours of operation are Monday – Friday, 9am – 5pm. Anyone who experiences a severe adverse event following immunisation (AEFI) should first seek medical attention from a health professional. For advice on symptoms following COVID-19 vaccines, we encourage callers to contact the Coronavirus Hotline on 1800 675 398 or see your GP.

SAEFVIC is a reporting service and not an emergency contact. Hours of operation are Monday – Friday, 9am – 5pm. Anyone who experiences a severe adverse event following immunisation (AEFI) should first seek medical attention from a health professional. For advice on symptoms following COVID-19 vaccines, we encourage callers to contact the Coronavirus Hotline on 1800 675 398 or see your GP.

AEFIs can be reported by the vaccine recipient, the vaccine provider or any health professional who reviews the recipient following their AEFI. For more information on reporting an AEFI, refer to SAEFVIC.

SAEFVIC 2022 influenza vaccination support

Afluria® Quad vaccine is contraindicated in children open disclosure process and made aware of the potential side effects and how to manage them. The error should also be reported to SAEFVIC as soon as possible.

If a second influenza vaccine is required for this season, an age-appropriate brand should be used to complete the course. For further information on influenza vaccine recommendations refer to MVEC: Influenza.

Fluad®Quad and Fluzone High Dose Quad are both adjuvanted quadrivalent influenza vaccines (QIV), only registered for use in older adults (Fluad Quad ≥ 65 years , Fluzone High Dose Quad ≥ 60 years).

Where a vaccine is administered outside of the recommended age range, the vaccine recipient should be advised of the error following the open disclosure process, informed of the potential for increased local side effects due to the adjuvant in the vaccine and advised how these side effects can be managed. This error should also be reported to SAEFVIC.

If a patient aged ≥ 60 years old (including those aged ≥ 65 years) has already received a dose of a 2022 standard QIV vaccine they do not need re-vaccination or booster dosing with an adjuvanted influenza vaccine.

SAEFVIC COVID-19 vaccination support

Anyone who has experienced a significant adverse event following a previous dose of a COVID-19 vaccine should first have their adverse event reported to SAEFVIC. They should then be referred to VicSIS for review and management of future COVID-19 vaccination. For further information on what constitutes a significant AEFI and the referral criteria for specialist immunisation services, refer to VicSIS.

The only two absolute contraindications to vaccination are anaphylaxis to a previous dose of the same vaccine or anaphylaxis to a component of the vaccineThere are also a small group of specific medical conditions for each COVID-19 vaccine brand, precluding some individuals from receiving that brand. These individuals can still receive vaccination with alternate vaccine platforms.

A medical exemption can only be approved by authorised practitioners.  SAEFVIC, MVEC and VicSIS Central are unable to provide medical exemptions. Following a VicSIS appointment with an immunisation specialist an exemption may be provided if deemed clinically appropriate. Due to significant waiting time for VicSIS appointments, referring clinicians may need to consider providing patients with a temporary exemption where clinically indicated whilst they wait for a VicSIS appointment.  

It may be appropriate for your GP to provide short-term vaccine exemption until it is determined if it is safe to proceed to routine vaccination or if a longer temporary exemption is required. You can find more information on exemptions here.

ATAGI recommends the use of the same COVID-19 vaccine for the two doses of the primary course of vaccination unless there are specific medical contraindications or precautions.

At this time there are no recommendations for a third vaccine dose in people who have received two different COVID-19 vaccines (with an interval between the doses of at least 14 days).

For further information refer to ATAGI COVID-19 vaccination – Clinical advice on the use of a different COVID-19 vaccine as the second dose.

For further information on VicSIS referrals and appointments please refer to the VicSIS support FAQs.

SAEFVIC vaccine error support

Cold chain breaches occur when vaccines are stored incorrectly, either outside the recommended temperature ranges or are exposed to light. Breaches in the cold chain can impact vaccine effectiveness and leave vaccine recipients unprotected.

Vaccines affected by a cold chain breach must not be used or discarded but should be isolated until further advice can be sought. Cold chain breaches must be reported to the appropriate authorities as soon as possible.

COVID-19 vaccine cold chain breaches must be reported to the Commonwealth Vaccine Operations Centre (VOC) via phone: 1800 318 208 or email: COVID19VaccineOperationsCentre@health.gov.au.

Non COVID-19 vaccine cold chain breaches in Victoria must be reported to the Victorian Department of Health.

If a vaccine that has been exposed to a cold chain breach is inadvertently administered to an individual, this is considered an error and must be reported to SAEFVIC (if the breach occurred in Victoria).

A vaccine error occurs when a vaccine is stored, prepared or administered incorrectly.

All vaccine errors should be reported online via SAEFVIC and clinical advice sought as soon as possible.

For clinical guidance on the management of COVID-19 vaccine administration errors, please refer to ATAGI clinical guidance on COVID-19 vaccine administration errors.

When a vaccine administration error occurs, affected individuals must be informed, following the open disclosure process.

Booster doses are not currently recommended for anyone aged <16 years.

The affected individual (and their parent/guardian) must be informed of the incident following the open disclosure process and are aware of the potential side effects and their management. The error must also be reported to SAEFVIC.

For further information on booster doses in adolescents refer to ATAGI clinical recommendations for COVID-19 vaccines: booster dose recommendations.

COVID-19 vaccines administered past the expiration or use-by date must be reported to the Commonwealth Vaccine Operations Centre (VOC) as soon as possible for advice via phone: 1800 318 208 or email: COVID19VaccineOperationsCentre@health.gov.au.

Administering a COVID-19 vaccine outside of the expiry or thaw “use by date” is considered an error and must be reported to SAEFVIC (if the breach occurred in Victoria).

For further information refer to the ATAGI clinical guidance on COVID-19 vaccine administration errors.

SAEFVIC website support

If you have forgotten your SAEFVIC password click here to reset it. You will receive a confirmation email to reset your password.

Still need help? Submit a request here and a member of the SAEFVIC team will be in touch.